Martin Shkreli, the 32-year-old CEO of Turing Pharmaceuticals, has steered his company into some controversy this week when it was revealed that they would be raising the price of the drug Daraprim from $13.50 to $750, a near 5000% increase in price. Greed in the pharmaceutical industry is nothing new, but with this story, it is hitting the media like it never has before.
Support Ring of Fire by subscribing to our YouTube channel.
Listen to Ring of Fire on Saturdays from 3pm-6pm Eastern! Listen live via the Progressive Voices Channel on TuneIn.
Watch Ring of Fire every weekday at 8:30pm EST on Free Speech TV!